Literature DB >> 23225227

The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease.

Raquel Duran1, Niccolo E Mencacci1,2, Aikaterini V Angeli3, Maryam Shoai1, Emma Deas1, Henry Houlden1, Atul Mehta4, Derralynn Hughes4, Timothy M Cox5, Patrick Deegan5, Anthony H Schapira6, Andrew J Lees1, Patricia Limousin3, Paul R Jarman3, Kailash P Bhatia3, Nicholas W Wood1, John Hardy1, Tom Foltynie3.   

Abstract

BACKGROUND: Heterozygous loss-of-function mutations in the acid beta-glucocerebrosidase (GBA1) gene, responsible for the recessive lysosomal storage disorder, Gaucher's disease (GD), are the strongest known risk factor for Parkinson's disease (PD). Our aim was to assess the contribution of GBA1 mutations in a series of early-onset PD.
METHODS: One hundred and eighty-five PD patients (with an onset age of ≤50) and 283 age-matched controls were screened for GBA1 mutations by Sanger sequencing.
RESULTS: We show that the frequency of GBA1 mutations is much higher in this patient series than in typical late-onset patient cohorts. Furthermore, our results reveal that the most prevalent PD-associated GBA1 mutation is E326K, a variant that does not, when homozygous, cause GD.
CONCLUSIONS: Our results confirm recent reports that the mutation, E326K, predisposes to PD and suggest that, in addition to reduced GBA1 activity, other molecular mechanisms may contribute to the development of the disease.
Copyright © 2012 Movement Disorders Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23225227      PMCID: PMC4208290          DOI: 10.1002/mds.25248

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  26 in total

1.  Is E326K glucocerebrosidase a polymorphic or pathological variant?

Authors:  Benjamin Liou; Gregory A Grabowski
Journal:  Mol Genet Metab       Date:  2011-12-08       Impact factor: 4.797

2.  Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease.

Authors:  Amparo Chabás; Laura Gort; Anna Díaz-Font; Magdalena Montfort; Raül Santamaría; Manuel Cidrás; Daniel Grinberg; Lluïsa Vilageliu
Journal:  Blood Cells Mol Dis       Date:  2005 Sep-Oct       Impact factor: 3.039

3.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Authors:  E Sidransky; M A Nalls; J O Aasly; J Aharon-Peretz; G Annesi; E R Barbosa; A Bar-Shira; D Berg; J Bras; A Brice; C-M Chen; L N Clark; C Condroyer; E V De Marco; A Dürr; M J Eblan; S Fahn; M J Farrer; H-C Fung; Z Gan-Or; T Gasser; R Gershoni-Baruch; N Giladi; A Griffith; T Gurevich; C Januario; P Kropp; A E Lang; G-J Lee-Chen; S Lesage; K Marder; I F Mata; A Mirelman; J Mitsui; I Mizuta; G Nicoletti; C Oliveira; R Ottman; A Orr-Urtreger; L V Pereira; A Quattrone; E Rogaeva; A Rolfs; H Rosenbaum; R Rozenberg; A Samii; T Samaddar; C Schulte; M Sharma; A Singleton; M Spitz; E-K Tan; N Tayebi; T Toda; A R Troiano; S Tsuji; M Wittstock; T G Wolfsberg; Y-R Wu; C P Zabetian; Y Zhao; S G Ziegler
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

4.  The E326K mutation and Gaucher disease: mutation or polymorphism?

Authors:  J K Park; N Tayebi; B K Stubblefield; M E LaMarca; J J MacKenzie; D L Stone; E Sidransky
Journal:  Clin Genet       Date:  2002-01       Impact factor: 4.438

5.  Two new mild homozygous mutations in Gaucher disease patients: clinical signs and biochemical analyses.

Authors:  B Cormand; D Grinberg; L Gort; A Fiumara; R Barone; L Vilageliu; A Chabás
Journal:  Am J Med Genet       Date:  1997-06-27

6.  Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset.

Authors:  W C Nichols; N Pankratz; D K Marek; M W Pauciulo; V E Elsaesser; C A Halter; A Rudolph; J Wojcieszek; R F Pfeiffer; T Foroud
Journal:  Neurology       Date:  2008-11-05       Impact factor: 9.910

7.  Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Authors:  Nathan Pankratz; Gary W Beecham; Anita L DeStefano; Ted M Dawson; Kimberly F Doheny; Stewart A Factor; Taye H Hamza; Albert Y Hung; Bradley T Hyman; Adrian J Ivinson; Dmitri Krainc; Jeanne C Latourelle; Lorraine N Clark; Karen Marder; Eden R Martin; Richard Mayeux; Owen A Ross; Clemens R Scherzer; David K Simon; Caroline Tanner; Jeffery M Vance; Zbigniew K Wszolek; Cyrus P Zabetian; Richard H Myers; Haydeh Payami; William K Scott; Tatiana Foroud
Journal:  Ann Neurol       Date:  2012-03       Impact factor: 10.422

8.  Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.

Authors:  Michael A Nalls; Vincent Plagnol; Dena G Hernandez; Manu Sharma; Una-Marie Sheerin; Mohamad Saad; J Simón-Sánchez; Claudia Schulte; Suzanne Lesage; Sigurlaug Sveinbjörnsdóttir; Kári Stefánsson; Maria Martinez; John Hardy; Peter Heutink; Alexis Brice; Thomas Gasser; Andrew B Singleton; Nicholas W Wood
Journal:  Lancet       Date:  2011-02-01       Impact factor: 79.321

9.  Novel pathogenic mutations in the glucocerebrosidase locus.

Authors:  Raquel Duran; Alisdair McNeill; Atul Mehta; Derralyn Hughes; Timothy Cox; Patrick Deegan; Anthony H V Schapira; John Hardy
Journal:  Mol Genet Metab       Date:  2012-05-18       Impact factor: 4.797

10.  Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.

Authors:  Matthew E Gegg; Derek Burke; Simon J R Heales; J Mark Cooper; John Hardy; Nicholas W Wood; Anthony H V Schapira
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

View more
  50 in total

1.  Genome-wide assessment of Parkinson's disease in a Southern Spanish population.

Authors:  Sara Bandrés-Ciga; Timothy Ryan Price; Francisco Javier Barrero; Francisco Escamilla-Sevilla; Javier Pelegrina; Sampath Arepalli; Dena Hernández; Blanca Gutiérrez; Jorge Cervilla; Margarita Rivera; Alberto Rivera; Jing-Hui Ding; Francisco Vives; Michael Nalls; Andrew Singleton; Raquel Durán
Journal:  Neurobiol Aging       Date:  2016-06-11       Impact factor: 4.673

2.  Arylsulphatase A activity in familial parkinsonism: a pathogenetic role?

Authors:  Elena Antelmi; Giovanni Rizzo; Margherita Fabbri; Sabina Capellari; Cesa Scaglione; Paolo Martinelli
Journal:  J Neurol       Date:  2014-07-03       Impact factor: 4.849

3.  Progressive Supranuclear Palsy-Like Phenotype in a GBA E326K Mutation Carrier.

Authors:  Marina Picillo; Simona Petrucci; Enza Maria Valente; Sabina Pappatà; Fiorenzo Squame; Monia Ginevrino; Leonardo Pace; Paolo Barone; Maria Teresa Pellecchia
Journal:  Mov Disord Clin Pract       Date:  2016-07-27

4.  Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.

Authors:  Laurie A Robak; Iris E Jansen; Jeroen van Rooij; André G Uitterlinden; Robert Kraaij; Joseph Jankovic; Peter Heutink; Joshua M Shulman
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

Review 5.  Genetic risk factors in Parkinson's disease.

Authors:  K J Billingsley; S Bandres-Ciga; S Saez-Atienzar; A B Singleton
Journal:  Cell Tissue Res       Date:  2018-03-13       Impact factor: 5.249

6.  Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease.

Authors:  Jennifer A Ruskey; Lior Greenbaum; Léanne Roncière; Armaghan Alam; Dan Spiegelman; Christopher Liong; Oren A Levy; Cheryl Waters; Stanley Fahn; Karen S Marder; Wendy Chung; Gilad Yahalom; Simon Israeli-Korn; Vered Livneh; Tsvia Fay-Karmon; Roy N Alcalay; Sharon Hassin-Baer; Ziv Gan-Or
Journal:  Eur J Med Genet       Date:  2018-05-26       Impact factor: 2.708

Review 7.  Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.

Authors:  Ravindran Kumaran; Mark R Cookson
Journal:  Hum Mol Genet       Date:  2015-06-22       Impact factor: 6.150

Review 8.  The ongoing pursuit of neuroprotective therapies in Parkinson disease.

Authors:  Dilan Athauda; Thomas Foltynie
Journal:  Nat Rev Neurol       Date:  2014-12-02       Impact factor: 42.937

Review 9.  Genetic convergence of Parkinson's disease and lysosomal storage disorders.

Authors:  Hao Deng; Xiaofei Xiu; Joseph Jankovic
Journal:  Mol Neurobiol       Date:  2014-08-07       Impact factor: 5.590

Review 10.  Parkinson's disease: an update on pathogenesis and treatment.

Authors:  Tom Foltynie; Joshua Kahan
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.